/
MASS
$8.81+$0.03 (+0.34%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$332.0M
38M shares
52-week range
$5.03 – $9.34
88% from low
Sector
MEASURING & CONTROLLING DEVICES, NEC
Exchange
NASDAQ
CS
Borrow rate
0.44%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-29.94
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.1M | $18.0M | $26.9M | $42.2M | $46.9M | $50.2M | $59.6M | $56.2M |
| Cost of revenue | $9.7M | $9.8M | $12.0M | $19.0M | $20.8M | $24.9M | $29.7M | $29.4M |
| Gross profit | $12.4M | $8.1M | $14.9M | $23.2M | $26.0M | $25.3M | $29.9M | $26.8M |
| Gross margin | 56.2% | 45.3% | 55.5% | 55.0% | 55.5% | 50.4% | 50.2% | 47.7% |
| R&D | $9.5M | $9.0M | $8.2M | $13.1M | $17.5M | $21.9M | $25.5M | $13.8M |
| Operating income | −$6.4M | −$12.1M | −$5.8M | −$22.1M | −$35.4M | −$42.8M | −$76.7M | −$24.2M |
| EBITDA | −$5.5M | −$11.2M | −$5.0M | −$20.8M | −$31.8M | −$40.3M | −$43.9M | −$28.9M |
| Net income | −$7.5M | −$13.4M | −$12.8M | −$22.2M | −$33.6M | −$36.4M | −$72.2M | −$36.6M |
| Net margin | -34.2% | -74.4% | -47.7% | -52.5% | -71.6% | -72.5% | -121.1% | -65.2% |
| EPS (diluted) | -0.93 | -2.02 | -2.35 | -0.79 | -1.07 | -1.13 | -2.12 | 0.54 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $69M | $-0.29 | $-0.29–$-0.28 | 2 |
| 2027 | $82M | $-0.31 | $-0.54–$-0.08 | 2 |
| 2028 | $100M | $-0.24 | $-0.24–$-0.24 | 1 |
| 2029 | $102M | $-0.20 | $-0.20–$-0.20 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
908 Devices Inc. Common Stock
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
www.908devices.com- Employees
- 172
- IPO / List date
- Dec 18, 2020
- HQ
- BURLINGTON, MA
Held by traders on TradeandTell
No one on the platform currently holds MASS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 230,200 | $1.4M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MASS yet.
